研究業績 2026年度（2026年4月～2027年3月）
原 著2026
スタッフ * 責任著者
- Keino-Masu K, Okada T, Yamasaki N, Horiuchi Y, Arinami T, Hagino Y, Ikeda K, Miyakawa T, *Masu M.
Comprehensive behavioral phenotyping of male Sulf1-deficient mice reveals reduced locomotor activity, altered forelimb gait, and reduced prepulse inhibition. (Open Access)
Mol Brain Mol Brain 19(1):73. 査読有 doi: 10.1186/s13041-026-01353-8. - Umemura F, Kotajima-Murakami H, Strickland JC, Garcia-Romeu A, Johnson MW, *Ikeda K (2026)
Development of Japanese versions of the 4-item Mystical Experience Questionnaire and 7-item Challenging Experience Questionnaire. (Open Access)
Neuropsychopharmacol Rep 46(3):e70164. 査読有 doi: 10.1002/npr2.70164. - Okochi R, *Ogata G, Fujita M, Jiang L, Ide S, Kobayashi K, Ikeda K, *Einaga Y (2026)
Multi-step amperometry for detecting dopamine using boron-doped diamond microelectrodes in the striatum of the mouse brain.
ACS Sens 11(8):6886-6894. 査読有 doi: 10.1021/acssensors.6c00787. - *Yamada K, Nishizawa D, Arita H, Hanaoka K, Yajima C, Kato J, Ogawa S, Hiranuma A, Hasegawa J, Ebata Y, Nakayama K, Iseki M, Ikeda K.
Dopamine transporter gene (SLC6A3) polymorphism rs2963257 and chronic pain susceptibility in a Japanese population. (Open Access)
Pain Rep 11(4):e1478. 査読有 doi: 10.1097/PR9.0000000000001478. - Owada H, Nishizawa D, Mieda T, Tsujita M, Nakagawa H, Yamaguchi S, Tsuchida R, Yokoshima Y, Kitamura A, Hayashida M, Fukuda K, Ichinohe T, Ikeda K, Kurano M, Sumitani M, Uchida K (2026)
The rs10781468 Genetic Polymorphism of the Gαq (GNAQ) Gene Is Associated With Responsiveness to Opioid Analgesics in Patients With Postoperative and Cancer Pain: An Exploratory Study
(Open Access)
Neuropsychopharmacol Rep 46(3):e70148. 査読有 doi: 10.1002/npr2.70148. - Nakagawa H, *Nishizawa D, Mieda T, Tsujita M, Kasai S, Hasegawa J, Nakayama K, Ebata Y, Kitamura, Hayashida M, *Ikeda K.
Sex difference in effect of the OPRM1 gene A118G (rs1799971) single-nucleotide polymorphism on the requirement for postoperative fentanyl in Japanese patients who underwent laparoscopic-assisted colectomy. (Open Access)
Neuropsychopharmacol Rep 46(2):e70140. 査読有 doi: 10.1002/npr2.70140. - *Ohi K, Nishizawa D, Fujikane D, Hasegawa J, Sato N, Tanioka F, Sugimura H, Ikeda K, Shioiri T.
Genetic predispositions for anxiety disorders and major depressive disorder affect current dietary habits in older patients with lifestyle-related diseases short title: Genetic risks for anxiety and depression and dietary habits. (Open Access)
Int J Neuropsychopharmacol 29(4):pyag014. 査読有 doi: 10.1093/ijnp/pyag014. - *Hagihara H, Koshimizu H, Hattori S, Shoji H, Tanaka M, Ikeda K, *Miyakawa T (2026)
Hyper-maturity and accelerated aging in the hippocampus of mouse models of neuropsychiatric disorders with anxiety-like behavior. (Open Access)
Neuropsychopharmacology51(5):856-867. 査読有 doi: 10.1038/s41386-025-02237-6.
総 説2026
スタッフ * 責任著者
- *Uchida H, Gobbi G, Zohar J, Young AH, Rujescu D, Huang MC, Sundram S, Atwoli L, Vukovic J, *Ikeda K.
Global perspectives on CNS drug innovation: achievements, barriers, and priorities for the next decade. (Open Access)
Int J Neuropsychopharmacol 29(8):pyag023. 査読有 doi: 10.1093/ijnp/pyag023. - Kamijo S, Miwa H, *Ikeda K.
Autism spectrum disorder: Integrating genetic and environmental risk.
Cells 15(11):985. 査読有 doi: 10.3390/cells15110985. - *Ide S, Nishitani Y, Sumitani M, Minami M, Isa T, Iseki M, Ohkura M, Okamoto H, Kikuchi T, Sekino Y, Takahashi H, Takeuchi K, Nitta A, Honjo T, Matsumoto H, Miyakawa T, Murai T, Matsumoto T, Nakagome K, Ikeda K.
Addiction-related problems in Japan: A regional perspective. (Open Access)
Addiction 121(5):1316-1324. 査読有 doi: 10.1111/add.70307.
学会等発表（招待講演）2026
スタッフ * 学会発表者
- *Ikeda K (2026)
Emerging Neuropsychopharmacology based on the link between basic and clinical sciences.
The 11th World Congress of Asian Psychiatry, 札幌 [2026/10/07].
学会等発表（その他）2026
スタッフ * 学会発表者
- *西澤大輔, 照井健, 石谷邦彦, 笠井慎也, 長谷川準子, 中山京子, 池田和隆 (2026)
日本人がん患者における喫煙行動の遺伝学的基盤の解明：1日喫煙本数を対象としたゲノムワイド関連解析.
BCNP2026合同年会, 宇都宮 [2026/10/31]. - *榎本彬乃, 大岡静衣, 西澤大輔, 大谷保和, 笠井慎也, 井手聡一郎, 長谷川準子, 中山京子, 林田眞和, 松浦信幸, 一戸達也, 福田謙一, 池田和隆 (2026)
GABRA5 rs35399885 一塩基多型は術後知覚鈍麻および疼痛感受性と有意に関連する.
BCNP2026合同年会, 宇都宮 [2026/10/31]. - *池田和隆 (2026)
国際精神神経薬理学における日本のプレゼンス：CINP・AsCNPとの連携と連合の意義.
BCNP2026合同年会, 宇都宮 [2026/10/31]. - *大岡静衣, 長谷川準子, 中山京子, 西澤大輔, 川路英哉, 嶋多美穂子, 山田壮一, 福井良子, 福士秀悦, 池田和隆 (2026)
慢性疼痛関連HS3ST4遺伝子一塩基多型領域から転写される新規RNAがヒト神経系で存在する.
BCNP2026合同年会, 宇都宮 [2026/10/31]. - *西澤大輔, 池田和隆 (2026)
アルコール健康障害の遺伝子解析―東京都における一般人口飲酒問題調査研究結果をもとに―.
2026年度アルコール・薬物依存関連学会合同学術総会, 札幌 [2026/10/10]. - *西澤大輔, 長谷川準子, 中山京子, 池田和隆 (2026)
喫煙行動の多遺伝子要因の網羅的解析及び他の習慣的行動等形質との関連性の解明.
公益財団法人喫煙科学研究財団 第40回令和7年度助成研究発表会, 東京 [2026/07/17]. - *笠井慎也, 山口保晴, 長谷川準子, 池田和隆 (2026)
発達期の食生活が喫煙行動におよぼす影響の解明.
公益財団法人喫煙科学研究財団 第40回令和7年度助成研究発表会, 東京 [2026/07/17]. - *Nakamoto Y, Nakamura K, Ikeda K, Yoshii M (2026)
Gender and age differences in association between translocator protein 18 kDa (TSPO) gene polymorphism and trait anxiety in normal human subjects.
37th CINP World Congress of Neuropsychopharmacology, Glasgow, UK [2026/06/28]. - *Nago-Iwashita Y, Kanata T, Oba M, Ikeda K, Nishizawa D (2026)
Association of alcohol-related genetic polymorphisms with problematic alcohol use and suicidal ideation.
37th CINP World Congress of Neuropsychopharmacology, Glasgow, UK [2026/06/28]. - *Moriya Y, Saito-Moriya R, Nago-Iwashita Y, Sora I, Maki SA, Aoyama H, Ikeda K (2026)
Low-dose novel FLT3 inhibitor demonstrates non-opioid analgesic efficacy in thermal and inflammatory pain models.
37th CINP World Congress of Neuropsychopharmacology, Glasgow, UK [2026/06/28]. - *Nishizawa D, Hasegawa J, Nakayama K, Fukuda K-i, Ichinohe T, Nagashima M, Hayashida M, Trang T, Ikeda K (2026)
RUNX1 variant rs2236431 is associated with postoperative opioid analgesic requirements in humans.
37th CINP World Congress of Neuropsychopharmacology, Glasgow, UK [2026/06/28]. - *Enomoto A, Ohka S, Nishizawa D, Ogai Y, Kasai S, Ide S, Hasegawa J, Nakayama K, Hayashida M, Matsuura N, Ichinohe T, Fukuda K, Ikeda K (2026)
GABRA5 rs35399885 single nucleotide polymorphism is significantly associated with sensory hypoesthesia and pain sensitivity.
37th CINP World Congress of Neuropsychopharmacology, Glasgow, UK [2026/06/28]. - *Yamaguchi Y, Kasai S, Hasegawa J, Ikeda K (2026)
Smoking is associated with eating habits during development.
37th CINP World Congress of Neuropsychopharmacology, Glasgow, UK [2026/06/27]. - *Ide S, Ikekubo Y, Uhl GR, Sora I, Ikeda K (2026)
Dopaminergic hyperactivity enhances persistent intracranial self-stimulation with reward delivered at random responses within fixed response blocks.
37th CINP World Congress of Neuropsychopharmacology, Glasgow, UK [2026/06/27].
その他の発表2026
スタッフ
-
*井手聡一郎 (2026)
過剰使用の抑制/過少投与の回避 日本が抱える二重の課題 [取材]
信濃毎日新聞 [2026/10/29] -
*池田和隆 (2026)
アディクションを引き起こす神経伝達物質システム [講演]
藤田医科大学ブレインサイエンスセミナー, 藤田医科大学, 豊明 [2026/04/22].
特記事項2026
スタッフ
- 池田和隆 (2026)
合同年会指定企画シンポジウム7：精神・神経疾患創薬はなぜ難しいのか？[オーガナイザー・座長]
BCNP2026合同年会, ライトキューブ宇都宮, 宇都宮 [2026/11/01]. - 池田和隆 (2026)
特別講演Ⅲ「イントロン・リテンションはホメオスタシス破綻の早期指標である」 [座長]
東京バイオマーカー・イノベーション技術研究会（TOBIRA）第14回TOBIRA研究交流フォーラム, ソラシティカンファレンスセンターソラシティホール, 東京 [2026/07/17]. - *Ikeda K, Krystal JH, Saito T (2026)
In memoriam—Shigeto Yamawaki, M.D., Ph.D. (1954–2026).
Neuropsychopharmacology doi: 10.1038/s41386-026-02482-3. - Zohar J, Ikeda K (2026)
Spotlight Session 5: The Way Forward: Major Significant Collaboration (Joint meeting with the leadership of WFSBP, WPA, ECNP, and CINP) [座長]
37th CINP World Congress of Neuropsychopharmacology, The Scottish Event Campus, Glasgow, UK [2026/06/29]. - Bai YM, Ikeda K (2026)
Keynote Lecture 6 [座長]
37th CINP World Congress of Neuropsychopharmacology, The Scottish Event Campus, Glasgow, UK [2026/06/29].